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Purpose: To evaluate the prevalence of esophageal reflux-induced symptoms after gastrectomy owing to gastric cancer and assess the 
relationship between esophageal reflux-induced symptoms and quality of life.
Materials and Methods: From January 2012 to May 2012, 332 patients were enrolled in this cross-sectional study. The patients had 
a history of curative resection for gastric cancer at least 6 months previously without recurrence, other malignancy, or ongoing chemo-
therapy. Esophageal reflux-induced symptoms were evaluated with the GerdQ questionnaire. The quality of life was evaluated with the 
European Organization for Research and Treatment QLQ-C30 and STO22 questionnaires.
Results: Of the 332 patients, 275 had undergone subtotal gastrectomy and 57 had undergone total gastrectomy. The number of 
GerdQ(+) patients was 58 (21.1%) after subtotal gastrectomy, and 7 (12.3%) after total gastrectomy (P=0.127). GerdQ(+) patients 
showed significantly worse scores compared to those for GerdQ(–) patients in nearly all functional and symptom QLQ-C30 scales, with 
the difference in the mean score of global health status/quality of life and diarrhea symptoms being higher than in the minimal important 
difference. Additionally, in the QLQ STO22, GerdQ(+) patients had significantly worse scores in every symptom scale. The GerdQ score 
was negatively correlated with the global quality of life score (r=-0.170, P=0.002).
Conclusions: Esophageal reflux-induced symptoms may develop at a similar rate or more frequently after subtotal gastrectomy compared 
to that after total gastrectomy, and decrease quality of life in gastric cancer patients. To improve quality of life after gastrectomy, new 
strategies are required to prevent or reduce esophageal reflux.
Key Words: Stomach neoplasms; Gastrectomy; Esophageal reflux; Quality of life
Correspondence to: Seung Ho Choi
Department of Surgery, Gangnam Severance Hospital, Yonsei 
University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-
720, Korea
Tel: +82-2-2019-3374, Fax: +82-2-3462-5994
E-mail: choish@yuhs.ac
Received January 27, 2014
Revised February 22, 2014
Accepted February 24, 2014
*Min Hye Im and Jong Won Kim contributed equally to this study as co-
first authors.
Copyrights © 2014 by The Korean Gastric Cancer Association www.jgc-online.org
 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original ArticleJ Gastric Cancer 2014;14(1):15-22  http://dx.doi.org/10.5230/jgc.2014.14.1.15
Introduction
Gastric cancer is still prevalent throughout the world, and long-
term survival has increased owing to early detection, improved 
surgical techniques, and combined therapy.1 After gastrectomy, 
anatomical changes and loss of function induce various symp-
toms that may affect a patient’s quality of life (QoL) after surgery. 
Therefore, postoperative QoL has received considerable attention, 
in addition to oncological outcomes, as there are many factors af-
fecting QoL after curative gastric resection for gastric cancer.2 In 
the general population, symptomatic gastroesophageal reflux dis-
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ease (GERD) negatively affects patients’ QoL.3,4 Healthy individuals 
have anatomical features in the esophagogastric junction, which 
prevent esophageal reflux. These anatomical features may be dis-
rupted after gastric surgery, resulting in esophageal reflux. Taken 
together, we can assume that a fair number of gastric cancer pa-
tients may suffer from reflux-related symptoms after gastrectomy, 
which may negatively affect their QoL. The prevalence and severity 
of reflux-related symptoms differ according to the extent of resec-
tion and/or reconstruction methods.5-7 Some studies have evaluated 
the reflux itself, assessed by scintigraphic methods, bilimetry, intra-
esophageal pH monitoring, or endoscopic changes of the esopha-
geal mucosa.8-10 However, these studies did not evaluate the impact 
of reflux-related symptoms on QoL after gastrectomy.
We were interested in the esophageal reflux-related symptoms 
and their correlation with QoL. A recent study in our institute in-
vestigated GERD using the GerdQ questionnaire.11 The GerdQ is 
a self-administered, patient-oriented questionnaire developed by 
combining 6 questions from 3 different validated tools (the Reflux 
Disease Questionnaire, Gastrointestinal Symptom Rating Scale, 
and GERD Impact Scale),12-14 which are considered to have a high 
accuracy for symptom-based diagnosis of GERD in the general 
population.15-17 Therefore, the GerdQ questionnaire was used to 
evaluate esophageal reflux symptoms in this study. 
Furthermore, the European Organization for Research and 
Treatment (EORTC) QLQ-C30 and QLQ-STO22 questionnaires 
were used for evaluating the QoL in this study. Since its release in 
1993, the EORTC QLQ-C30 has become one of the most widely 
used ‘core’ instruments for the study of the health-related QoL of 
cancer patients, having been translated into several languages and 
used in hundreds of studies. The 14 single-item and multi-item 
scales in the EORTC QLC-C30 questionnaire assess physical and 
psychosocial functioning, key symptoms, and overall health-related 
QoL. The QLQ-C30 and its QLQ-STO22 disease-specific ques-
tionnaire module for patients with gastric cancer are used in com-
bination, and these questionnaires are usually selected because they 
are fully validated, translated into many languages, and adequate for 
multicultural comparisons.2,18
In this study, we evaluated reflux-related symptoms using the 
GerdQ questionnaire and analyzed the prevalence of reflux-related 
symptoms and their impact on QoL after gastrectomy in gastric 
cancer patients. 
Materials and Methods
This study was cross-sectional in design and was carried out at 
the Gastric Cancer Hospital, Gangnam Severance Hospital (Seoul, 
Korea). Eligible patients had a history of curative resection for 
gastric cancer ＞6 months previously and the ability to understand 
the nature of the study and communicate with the study personnel. 
Patients with evidence of recurrence of gastric cancer or any other 
malignancy, and those receiving chemotherapy were excluded from 
the study. Patients were recruited when they visited outpatient clin-
ics in Gangnam Severance Hospital for follow-up or investigation 
of gastrointestinal symptoms from January 2012 to May 2012. The 
study was approved by the institutional review board at the Gang-
nam Severance Hospital (IRB #3-2012-0054). Demographic data 
on gender and age, and clinical data were collected from patient 
interviews and medical records. 
A total of 346 patients visited our clinic during the study pe-
riod and completed the questionnaires. We excluded 1 patient with 
recurrent gastric cancer, 1 patient with liver metastasis, and 12 
patients who did not complete the GerdQ correctly. As a result, the 
data from a total of 332 patients were analyzed.
Postoperative symptoms related to esophageal reflux were as-
sessed using the GerdQ questionnaire (Korean translation). The 
GerdQ questionnaire is composed of 4 positive predictors of GERD 
(heartburn, regurgitation, sleep disturbance due to reflux symptoms, 
and the use of over-the-counter medication; questions 1, 2, 5, and 
6, respectively), and 2 negative correlates with GERD (epigastric 
pain and nausea; questions 3 and 4, respectively).14,19 The GerdQ 
scores were based on the frequency of 6 items during the past 7 
days ranging from 0 to 3 for the positive predictors, and from 3 to 0 
(in reversed order, with 3 representing ‘none’) for negative predic-
tors. The total GerdQ score is calculated as the sum of these scores, 
ranging from 0 to 18. Patients without any symptoms will have a 
GerdQ score of 6, and GERD patients will have a GerdQ score of 
＞8.15 In our study, patients with a total GerdQ score of ＞8 were 
assigned to the GerdQ (+) group, whereas patients with a total 
GerdQ score of 0 to 7 were assigned to the GerdQ (-) group.15
The QoL was assessed using the Korean version of the EORTC 
Core 30 (QLQ-C30) and a gastric cancer-specific module, the 
EORTC QLQ-STO22.20-23 The EORTC QLQ-C30 is a 30-item 
questionnaire, with both multi-item scales and single-item mea-
sures, including 5 functional scales (physical, role, cognitive, emo-
tional, and social), 3 symptom scales (fatigue, nausea and vomiting, 
and pain), a global health status/QoL scale, and 6 single items 
(dyspnea, insomnia, appetite loss, constipation, diarrhea, and finan-
cial difficulties). The EORTC QLQ-STO22 consists of 22 items 
and includes 5 multi-item scales and 4 single-item measures. 
All QLQ-C30 and QLQ-STO22 responses were scored using 
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4-point Likert scales and were linearly transformed to a 0 to 100 
score according to the scoring manual provided by the EORTC. A 
high score for the global health status/QoL represents high QoL, 
and a high score for the multi-item functional scales represents a 
high/healthy level of functioning. Conversely, in symptom scales/
single-items and all questions of the STO22, a high score reflects 
more symptoms or problems.24 
Statistical analyses were completed using SPSS 19.0 (IBM Co., 
Armonk, NY, USA). The t-test and chi-square test were used to 
compare differences in clinicopathologic characteristics between 
the 2 groups, (t-test, for continuous variables; chi-square test, for 
nominal variables). QoL after gastrectomy in patients with gas-
tric cancer was compared between the GerdQ (+) and GerdQ (-) 
groups. 
For each domain of the QLQ-C30 and QLQ-STO22 ques-
tionnaires, we calculated the minimal important difference (MID), 
defined as the smallest change that patients would identify as im-
portant. We followed the EORTC published guidelines for the in-
terpretation of clinically relevant differences in QLQ-C30 scores.25 
However, similar guidelines are not available for the interpretation 
of QLQ-STO22 scores. We therefore defined the MID for the 
domains of QLQ-STO22 as an effect size ＞0.5, which empiri-
cally yields nearly identical values to the clinical interpretation of a 
‘moderate difference’.26,27 The effect size was calculated as the dif-
ference between the means in the 2 groups divided by the pooled 
standard deviation.28 
The correlation between the GerdQ score and the global health 
status/QoL scale was analyzed. A P-value of ＜0.05 was consid-
ered statistically significant. 
Results
Three hundred and thirty-two patients were surveyed, including 
215 men and 117 women (male : female=1.85 : 1) with a mean age 
of 59.8±11.6 years. The number of subjects in the GerdQ (+) and 
GerdQ (-) groups was 65 and 267, respectively. The mean postop-
erative follow-up duration was 49.7±81.1 months.
There were no significant differences in age, gender, or pre-
operative body mass index between the GerdQ (+) and GerdQ (-) 
groups. In addition, there were no significant differences in opera-
tion time, operative approach methods, TNM stage, or postopera-
tive follow-up duration between the 2 groups (Table 1). Interest-
ingly, only 12.3% of patients undergoing total gastrectomy suffered 
from reflux symptoms, whereas 21.1% of patients undergoing 
subtotal gastrectomy suffered from reflux symptoms. Although the 
prevalence of reflux symptoms was higher in patients after subtotal 
gastrectomy than after total gastrectomy, the difference was not 
statistically significant (P=0.127). 
The differences between the means and MIDs of the QLQ-C30 
domains are shown in Fig. 1 and 2. 
With regard to the MID, the difference between the means and 
MIDs was greater in the domains of the global health status/QoL, 
which means that the global health status/QoL in the GerdQ (+) 
group was worse than that in the GerdQ (-) group (Fig. 1). On 
the functional scales based on physical, role, emotional, cogni-
Table 1. Clinicopathologic parameters
Variable GerdQ (+)* (n=65)
GerdQ (–)† 
(n=267) P-value 
Age (yr) 61.92±12.28 
(32~88)
59.29±11.42 
(28~87)
0.102 
Gender
   Male 40 (18.6) 175 (81.4) 0.544 
   Female 25 (21.4) 92 (78.6)
BMI (kg/m2) 23.25±2.84 
(17.62~29.62)
23.97±3.36 
(15.64~38.50)
0.197 
Approach methods
   Open 23 (20.0) 92 (80.0) 0.879 
   Laparoscopy 42 (19.4) 174 (80.6)
   Robot 0 (0.0) 1 (100.0)
Extent of gastrectomy
   Subtotal 58 (21.1) 217 (78.9) 0.127 
   Total 7 (12.3) 50 (87.7)
Reconstruction
   Subtotal 0.131
      B-I 46 (21.7) 166 (78.3)
      B-II 11 (26.2) 31 (73.8)
      R-Y 1 (4.8) 20 (95.2)
   Total 0.706
      J-I 0 (0.0) 1 (100.0)
      R-Y 7 (12.5) 49 (87.5)
TNM stage
   I 55 (20.4) 214 (79.6) 0.600 
   II 5 (13.2) 33 (86.8)
   III 5 (20.0) 20 (80.0)
Postoperative duration (mo) 48.4±33.6 
(6.5~133.2)
45.4±37.4 
(6.2~226.7)
0.553
Values are presented as mean±standard deviation (range) or number 
(%). BMI = body mass index; B-I = Billroth I; B-II = Billroth II; R-Y = 
Roux-en-Y; J-I = jejunal interposition. *GerdQ score ≥8, †GerdQ score 
<8.
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tive, and social functioning, the score in the GerdQ (+) group was 
significantly lower than that in the GerdQ (-) group. However, the 
difference of the means was not greater than that of the MIDs. The 
EORTC QLQ-C30 guidelines did not provide the MID value for 
the emotional function domain.25 Therefore, we could not com-
pare the difference of means and MIDs in that domain. The scores 
based on the symptom scales in the EORTC QLQ-C30 question-
naire are shown in Fig. 2. The scores in the GerdQ (+) group were 
significantly inferior to those in the GerdQ (-) group on most of 
the symptom scales. However, the difference of the means was 
greater than that of the MIDs only for diarrhea (Fig. 2). 
Fig. 3 shows the effect sizes of the QLQ-STO22 domains. As 
expected, the effect size was ＞0.5 in the reflux domains, sug-
gesting that the GerdQ (+) group had worse reflux symptoms 
compared to those in the GerdQ (-) group based on the EORTC 
QLQ-STO22 scores. Additionally, the effect size was ＞0.5 in the 
domains of eating restriction and body image. 
The bivariate correlation analysis revealed that the GerdQ 
score was negatively correlated to the global health status/QoL 
scales (r=-0.170, P=0.002). Furthermore, the bivariate analysis 
performed in patients with a GerdQ score ＞6, revealed a negative 
correlation (r=-0.305, P＜0.001) (Fig. 4). 
Discussion
GERD in the general population is one of the most common 
diseases in Western countries, while in Asia the incidence of GERD 
is relatively low.29 GERD consists of 2 types: reflux esophagitis 
(RE), diagnosed by endoscopic observation, and non-erosive reflux 
disease (NERD), mainly diagnosed on the basis of upper gastro-
intestinal symptoms. NERD patients make up more than half of 
all GERD patients.30 In addition, symptomatic GERD is associated 
Fig. 1. Functional scales and global health status/quality of life (QoL) of 
the European Organization for Research and Treatment QLQ-C30. P-
values were calculated by t-test. GerdQ (+) =  GerdQ score ≥8; GerdQ 
(-) = GerdQ score <8; PF = physical function; RF = role function; EF = 
emotional function; CF = cognitive function; SF = social function; GQ 
= global QoL; DoM = difference of means; MID = minimal important 
difference. *Mark represents the domain with a difference greater than 
or equal to the MID. MIDs were from the article and the MID in the 
domain of the emotional function could not be determined from the 
article [25].
Fig. 2. Symptom scales of the European 
Organization for Research and Treat-
ment QLQ-C30. P-values were calculat-
ed by t-test. GerdQ (+) =  GerdQ score 
≥8; GerdQ (-) = GerdQ score <8; FA = 
fatigue; NV = nausea & vomiting; PA 
= pain; DN = dyspnea; IN = insomnia; 
AL = appetite loss; CO = constipation; 
DI = diarrhea; FD = financial difficul-
ties; DoM = difference of means; MID 
= minimal important difference. *Mark 
represents the domain with a difference 
greater than or equal to the MID. MIDs 
were from the article [25].
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with a substantial burden in affected individuals and society.3,4 
Reflux and other duodenal contents in the esophagus following 
total gastrectomy is considered to be a serious complication and a 
Roux-en-Y reconstruction has been used for diversion of the duo-
denal juices.31 Furthermore, reflux following proximal gastrectomy 
might be worse than reflux after total gastrectomy.32,33 However, it 
is difficult to fully understand the incidence of esophageal reflux 
after gastrectomy, because some reports have evaluated the reflux 
itself, while other reports have evaluated the endoscopic findings of 
the esophageal mucosa. A few studies have evaluated the symptoms 
related to esophagitis using different survey methods.34,35 After gas-
trectomy, some patients showing symptoms suggestive of esopha-
geal reflux such as heartburn and regurgitation did not demonstrate 
objective endoscopic findings.36 In this study, we evaluated the 
symptoms related to RE using the GerdQ questionnaire. Surpris-
ingly, over 20% of the patients with subtotal gastrectomy suffered 
from significant reflux symptoms, while only 12.3% of the patients 
with total gastrectomy suffered from GERD symptoms. Although 
the ratios of patients with GERD symptoms were not statistically 
significant between subtotal gastrectomy patients and total gastrec-
tomy patients, GERD may develop at a similar rate or more fre-
quently after subtotal gastrectomy than after total gastrectomy. To 
our knowledge, this appears to be the first report of such a finding. 
The causes of GERD after subtotal gastrectomy include a change 
in lower esophageal sphincter pressure, development of hiatal her-
nia, and blunting of the angle of His caused by pericardial lymph 
node dissection.37-40 However, the published literature on GERD 
patients after subtotal gastrectomy is not sufficient to clarify the 
pathogenesis of post-operative GERD, as researchers have been 
less concerned with GERD after subtotal gastrectomy than after 
total gastrectomy. However, the incidence of GERD after subtotal 
gastrectomy is not negligible, but rather similar or higher than that 
after total gastrectomy. A previous report found that heartburn 
symptoms were a complaint in 16 of 61 (26.2%) patients who un-
derwent partial gastrectomy, which is consistent with the findings 
in our study.41
Healthy individuals have anatomical features at the esophago-
gastric junction preventing esophageal reflux, which might be dis-
rupted by gastric surgery. As described above, symptomatic GERD 
in the general population is closely associated with QoL.3,4 The 
prevalence and severity of reflux-related symptoms differ accord-
ing to the extent of resection and/or reconstruction methods. Some 
Fig. 3. Symptom scales of the European 
Organization for Research and Treat-
ment QLQ-STO22. P-values were cal-
culated by t-test. GerdQ (+) =  GerdQ 
score ≥8; GerdQ (-) = GerdQ score 
<8; DP = dysphagia; PA = pain; RE = 
reflux; ER = eating restriction; AN = 
anxiety; DM = dry mouth; TA = taste; 
BI = body image; HL = hair loss. *Mark 
represents the domains with differences 
greater than or equal to the minimal 
important difference.
Fig. 4. Correlation analysis between the GerdQ score and Global 
health status/quality of life (QoL) scale. The solid line is the regression 
analysis line among all patients (r=-0.170, P=0.002). The dotted line is 
the regression line of the subgroup analysis in patients with a GerdQ 
score >6 (r=-0.305, P<0.001).
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studies evaluated the reflux itself, assessed by scintigraphic meth-
ods, bilimetry, intra-esophageal pH monitoring, or the endoscopic 
changes of the esophageal mucosa.8-10 However, these studies did 
not evaluate the impact of reflux-related symptoms on QoL after 
gastrectomy. The present study evaluated the impact of reflux-
related symptoms on QoL after gastrectomy in gastric cancer pa-
tients. Furthermore, we used the concept of MID to interpret the 
data. Many studies on the QoL in gastrectomized patients with gas-
tric cancer reported that the statistically significant differences were 
clinically relevant. However, the statistical significance of small dif-
ferences does not necessarily imply clinical importance. The MID 
proposes a threshold above which the outcome is experienced as 
clinically relevant by the patients.25,26 Reflux-related symptoms were 
significantly correlated with the global health status/QoL scales. 
Interestingly, diarrhea in EORTC QLQ-C30 symptom scales was 
clinically relevant in association with reflux-related symptoms. Fu-
ture studies need to investigate the correlation between diarrhea and 
reflux-related symptoms after gastrectomy, as we were unable to 
provide an explanation based on our study findings. In this study, 
we also demonstrated that reflux was clinically relevant to eating 
problems and body image, which are considered important factors 
by gastrectomized patients. Furthermore, the correlation analy-
sis between the GerdQ score and global health status/QoL scales 
showed that the GerdQ score is useful in the determination of QoL. 
Initially, subjects with no positive or negative reflux symptoms have 
a GerdQ score of 6, which increases if the subject has reflux symp-
toms. On the other hand, the GerdQ score decreases if the subject 
has negative reflux-related symptoms. Therefore, a GerdQ score 
of ＜6 indicates the presence of negative reflux-related symptoms 
that could affect patients’ QoL. For this reason, we analyzed the 
correlations again in a subpopulation with GerdQ scores of ＞6. As 
expected, a considerably higher correlation was observed between 
the GerdQ score and global health status/QoL scales (Fig. 4).
This study has some limitations. Esophageal reflux after total or 
subtotal gastrectomy could be different from GERD experienced in 
the general population, because the refluxate after gastrectomy has 
low or no acidity and patients do not have a pylorus. Therefore, the 
accuracy of the GerdQ score describing reflux symptoms in gas-
trectomized patients remains undetermined. In addition, the Korean 
version of the GerdQ questionnaire used in this study has not been 
officially validated. However, the GerdQ questionnaire covers all 
significant esophageal reflux related symptoms and there might be 
no other symptoms related to esophageal reflux in gastrectomized 
patients. Furthermore, the Korean version of the GerdQ question-
naire was successfully used in evaluation of GERD patients in a 
previous report.11
Although the refluxate after total gastrectomy is alkaline, its 
acidity is variable after subtotal gastrectomy. Truncal vagotomy re-
duces acid secretion of the remnant stomach in the early periods of 
gastrectomy, but it is restored with time.42 Patients with decreased 
esophageal sphincter function after subtotal gastrectomy eventually 
suffer from mixed acid and bile reflux. As the present study did 
not evaluate the composition of the refluxates, we did not confirm 
whether the acidity is correlated with the degree of the symptoms. 
Furthermore, the reconstruction methods after gastrectomy are 
important factors associated with reflux. A previous report sug-
gested the use of semifundoplication for prevention of GERD after 
subtotal gastrectomy.43 Additionally, a limited number of studies 
have demonstrated that Roux-en Y gastrojejunostomy is superior to 
Billroth I or Billroth II anastomosis for prevention of GERD after 
subtotal gastrectomy.5,44 In this study, we did not analyze the effects 
of the reconstruction methods owing to subgroup discrepancies.
RE has been considered as a typical aftereffect following total 
gastrectomy. However, esophageal reflux symptoms may develop 
at a similar frequency or more frequently after subtotal gastrectomy 
than after total gastrectomy. Esophageal reflux symptoms signifi-
cantly decrease the QoL of gastric cancer patients. Therefore, strat-
egies are required to prevent or reduce esophageal reflux symptoms 
in subtotal gastrectomy.
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